New ultrasound methods to measure liver health in people with normal scans
Part of Digestive system clinical trials.
This study tests two new ultrasound techniques, Attenuation Imaging and Shear Wave Elastography, during a routine endoscopic ultrasound to see if they can accurately measure liver fat and stiffness in people whose standard FibroScan is normal. It may help doctors detect early liver changes more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are already scheduled for a diagnostic endoscopic ultrasound (EUS) for another reason.
- You have had a FibroScan on the same day showing normal results (no significant liver fat or stiffness).
- You have no known chronic liver disease, hepatitis B or C, or heavy alcohol use.
- You are not pregnant, and have not had liver surgery or a liver tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special ultrasound technique during an endoscopy to see how well it can detect changes in the liver from non-alcoholic fatty liver disease. It may help improve non-invasive assessment before or alongside a follow-up liver biopsy.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This trial uses a special ultrasound during endoscopy to measure liver and spleen stiffness. It may replace liver biopsy for some patients with cirrhosis or unexplained high liver enzymes.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
Hear when a new Non-hepatobiliary Indications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.